7 Dec 2015 07:00
Collagen Solutions Plc
(the "Company" or the "Group")
Supply agreement with BBI Solutions
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces the execution of a supply agreement between Collagen Solutions (UK) Ltd and BBI Solutions OEM Limited ("BBI").
The supply agreement which will be for an initial three year period and on a rolling annual basis thereafter, will encompass the supply of Collagen Solutions' medical grade materials to support the research, pre-clinical and clinical development programmes of BBI's broad customer base.
Commenting on the agreement, Dr Stewart White, CEO of Collagen Solutions, said: "BBI has a renowned reputation for their knowledge in the reagent supply, diagnostics and development space and are therefore an excellent partner to enable collagen users to access our high quality medical grade GMP approved materials. We are very pleased to be working with Lyn and the team in Cardiff."
Lyn Rees, CEO of BBI Solutions added: "Our mission is to deliver exceptional products and technologies through innovation, partnership, effective delivery and collaboration. By working alongside the team at Collagen Solutions we can build on our expertise and reputation for supplying critical biological products into regulated markets. Our developing customer base in the advanced cellular and regenerative medicine markets are increasingly looking for collagen compounds. As a result, it was important for us to find a partner who can supply the high grade collagen they require consistently. Through this relationship with Collagen Solutions, we can continue to build our brand, improve the quality of people's lives and further our goals for the future in this transformational area of healthcare."
Enquiries:
Collagen Solutions Plc |
|
David Evans, Chairman | Tel: 07740 084 452 |
Stewart White, CEO | Tel: 0141 648 9100 |
|
|
Panmure Gordon & Co (Nominated Advisor and Broker) Robert Naylor (Corporate Finance) Maisie Atkinson (Corporate Broking) |
Tel: 0207 8862 714Tel: 0207 886 2905 |
|
|
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com |
Anna Dunphy | Mob: 07876 741 001 |
Mike Wort | Mob: 07900 608 002 |
|
|
BBI Solutions |
|
Lyn Rees, CEO | Tel: 029 207 47232 |
About BBI Solutions OEM Limited.
BBI Solutions is a leading supplier of biological raw materials and finished test platforms to the in-vitro diagnostic market. With over 50 years' experience, we have grown from a small specialist company to a global business with manufacturing sites spanning three continents.
We deliver exceptional products and services that people ultimately rely on to enjoy a better quality of life.
Our range of raw materials includes antigens, antibodies, enzymes and serum and plasma products. We manufacture world renowned labels for lateral flow and ELISA, including our gold nanoparticles, horseradish peroxidase and alkaline phosphatase. Our glucose oxidase is used in over 5 billion blood glucose monitoring test strips every year.
We offer end to end outsourced development and manufacturing services across a number of lateral flow and related platforms. Over 25 years, we have successfully completed more than 250 projects. Using the latest technologies and platforms, customers have come to rely on BBI to deliver next generation assay performance.
BBI Solutions is part of the BBI Group.